Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Comment on “Serum Amyloid β Oligomer May Predict Treatment Response in Middle‐Aged and Late‐Life Patients With Depression”
Saved in:
| Published in: | Neuropsychopharmacology Reports |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Comment on “Serum Amyloid β Oligomer May Predict Treatment Response in Middle‐Aged and Late‐Life Patients With Depression”
- Peripheral Nerve Conduction in Alzheimer’s vs. Late-Life Depression: A Comparative Study
- Wisdom and Life Purpose as Predictors of Mental Well-Being Among Middle-Aged to Older Adults: Cross-Sectional Study
- Tau burden across Braak stages is associated with regionally specific amyloid accumulation
- Impact of Physical Activity on Stroke Risk in Middle‐Aged and Older Adults
- Trajectories of quality of life, anxiety and depressive symptomatology, and health‐related work productivity after first seizure events
- We need to explain subjective experience, but its explanation may not be mechanistic